Lv4
600 积分 2023-03-09 加入
P0640 Development and characterization of LQ080, a novel extended half-life bispecific TL1A/IL-23 p19 single domain antibody for the treatment of IBD
1天前
待确认
Antibody Engineering Methods and Protocols
2个月前
已关闭
The pComb3 Phagemid Family of Phage Display Vectors
3个月前
已完结
A synthetic heavy chain variable domain antibody library (VHL) provides highly functional antibodies with favorable developability
3个月前
已完结
Current state and challenges in respiratory syncytial virus drug discovery and development
8个月前
已完结
皖公网安备34019202002308
